GAIN THERAPEUTICS INC's ticker is GANX and the CUSIP is 36269B105. A total of 24 filers reported holding GAIN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,211 | -26.7% | 3,723 | +0.1% | 0.00% | – |
| Q2 2023 | $16,657 | -6.9% | 3,718 | +0.1% | 0.00% | – |
| Q1 2023 | $17,897 | +54.0% | 3,713 | +0.0% | 0.00% | – |
| Q4 2022 | $11,619 | +29.1% | 3,712 | +36.9% | 0.00% | – |
| Q3 2022 | $9,000 | -10.0% | 2,711 | +1.3% | 0.00% | – |
| Q2 2022 | $10,000 | -9.1% | 2,675 | +0.1% | 0.00% | – |
| Q1 2022 | $11,000 | – | 2,673 | +11521.7% | 0.00% | – |
| Q4 2021 | $0 | – | 23 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 23 | -4.2% | 0.00% | – |
| Q2 2021 | $0 | – | 24 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|